Log-in
Sign-up
Webcast
Clinical Trials
Library
Webcast
Clinical Trials
Library
Home
>
Clinical Trials
Molecules
전체
Edoxaban
Olmesartan
Prasugrel
Pravastatin
Mirogabalin
Ramosetron
Trastuzumab deruxtecan
Status
Select
Check All
Search
Recruiting
Completed
Not yet recruiting
Enrolling by invitation
Active, not recruiting
Suspended
Terminated
Withdrawn
Unknown status
Email
Saved trials
COMPLETED
NCT00117494
Rosuvastatin Versus Pravastatin in HIV Patients Treated With Boosted Protease Inhibitors (PI) (ANRS126)
86
Enrollment(s)
1
Study location(s)
INTERVENTIONAL (PHASE4)
Hyperlipidemia
HIV Infections
RECRUITING
NCT06145308
Precision Treatment of Recurrent/Metastatic Salivary Gland Carcinoma Guided by Molecular Typing
39
Enrollment(s)
2
Study location(s)
INTERVENTIONAL (PHASE2)
Salivary Gland Carcinoma
Precision Therapy
TERMINATED
NCT05744375
Trastuzumab Deruxtecan in First-line HER2-positive Locally Advanced/MBC Patients Resistant to Trastuzumab+Pertuzumab
2
Enrollment(s)
19
Study location(s)
INTERVENTIONAL (PHASE2)
Locally Advanced Breast Cancer
Metastatic Breast Cancer
RECRUITING
NCT06740799
Assessment of Quizartinib Pharmacokinetic in Subjects With Severe Hepatic Impairment
12
Enrollment(s)
3
Study location(s)
INTERVENTIONAL (PHASE1)
Hepatic Impairment
ACTIVE_NOT_RECRUITING
NCT03793478
Safety and Efficacy of Quizartinib in Children and Young Adults With Acute Myeloid Leukemia (AML), a Cancer of the Blood
65
Enrollment(s)
27
Study location(s)
INTERVENTIONAL (PHASE1|||PHASE2)
Acute Myeloid Leukemia
RECRUITING
NCT07371585
Trastuzumab Deruxtecan in First-Line HER2-Positive Metastatic Breast Cancer With Proactive Toxicity Management
300
Enrollment(s)
27
Study location(s)
INTERVENTIONAL (PHASE2)
Breast Cancer Stage IV
ACTIVE_NOT_RECRUITING
NCT03568890
Short-Term Anticoagulation Versus Antiplatelet Therapy for Preventing Device Thrombosis Following Left Atrial Appendage Closure
510
Enrollment(s)
1
Study location(s)
INTERVENTIONAL (PHASE4)
Left Atrial Appendage Closure
Thrombosis
Stroke
TIA
Bleeding
COMPLETED
NCT04107727
Trial to Compare Efficacy and Safety of Chemotherapy/Quizartinib vs Chemotherapy/Placebo in Adults FMS-like Tyrosine Kinase 3 (FLT3) Wild-type Acute Myeloid Leukemia (AML)
273
Enrollment(s)
45
Study location(s)
INTERVENTIONAL (PHASE2)
Acute Myeloid Leukemia
21
22
23
24
25